Arwa Z. Al-Riyami: Opportunities for Transfusion Medicine Education Support
Arwa Z. Al-Riyami, Board Member of Oman Medical Journal, Forum Editor at International Society of Blood Transfusion (ISBT), shared a post on LinkedIn:
“Looking to strengthen transfusion medicine education in your region?
I have just completed the review of ISBT Academy applications for the Eastern Mediterranean region!
The International Society of Blood Transfusion (ISBT) Academy provides support to organizations delivering high-quality educational activities that advance transfusion medicine and cellular therapies worldwide.
Through the Academy, eligible organizations can apply for:
- Financial support for educational activities such as workshops, training courses, symposia, and congresses
- ISBT Highlight Days, bringing expert ISBT speakers and congress content to local meetings
- Permission to use the ISBT logo for eligible educational activities
- ISBT endorsement of established educational courses
Who is eligible?
- Established organizations (not individuals or commercial companies)
- Organizations in low-, lower-middle-, and upper-middle-income countries may apply for financial support.
- Organizations in high-income countries may apply for funding when it supports participants from eligible lower-income countries, and may also apply for ISBT logo use or course endorsement.
Application deadlines (2026 onwards):
- 1 March
- 1 July
- 1 November
Applications should be submitted at least four months before the planned event to allow sufficient time for review.
If your organization is planning an educational initiative that will strengthen transfusion medicine practice, this is an excellent opportunity to obtain ISBT Academy support!
Learn more about the ISBT Academy.
Eligibility, guidance, and application information.
Good luck to all this year’s applicants!”
Stay updated with Hemostasis Today.
-
Nov 7, 2026, 16:31Rafael Gomes: Is Dual Antiplatelet Therapy Still Necessary After LAAO?
-
Nov 7, 2026, 16:15Mazyar Shadman: Novel BTK Inhibitors and DOACs A Multicenter Study of Bleeding Risk
-
Nov 7, 2026, 15:54Hassan Raza: Beyond the 100 Minus Age Rule in Bone Marrow Cellularity
-
Nov 7, 2026, 15:42Andrew Zapfel։ Advancing Sickle Cell Disease Care Through Training, Advocacy and Collaboration
-
Nov 7, 2026, 15:34Salih Ehsan: Iron Deficiency Beyond Conventional Ferritin Cutoffs
-
Nov 7, 2026, 15:21Shamee Shastry: Improving the Reliability and Reproducibility of the Monocyte Monolayer Assay
-
Nov 7, 2026, 14:39AI-Assisted Donor Screening and Transfusion Decision Support: A Prospective Multicentre Evaluation
-
Nov 7, 2026, 14:26Qiong Tang: Changing Perspectives on Iron Deficiency and Supplementation
-
Nov 7, 2026, 14:21Nathan Connell: Bringing VWD Education Across Borders to Improve Patient Care